Tobacco Use and Treatment of Tobacco Dependence among People with Human Immunodeficiency Virus: A Pr
Thursday, September 15, 2022
Posted by: Natalia Gromov
Reddy KP, Kruse GR, Lee S,
Shuter J, Rigotti NA.
Tobacco Use and Treatment
of Tobacco Dependence among People with Human Immunodeficiency Virus: A
Practical Guide for Clinicians.
Clin Infect Dis. 2022;75(3):525-533. doi:10.1093/cid/ciab1069
More than 40% of people with human immunodeficiency virus (PWH) in the United
States smoke tobacco cigarettes. Among those on antiretroviral therapy, smoking
decreases life expectancy more than human immunodeficiency virus (HIV) itself.
Most PWH who smoke want to quit, but tobacco dependence treatment has not been
widely integrated into HIV care. This article summarizes the epidemiology of
tobacco use among PWH, health consequences of tobacco use and benefits of
cessation in PWH, and studies of treatment for tobacco dependence among the
general population and among PWH. We provide practical guidance for providers
to treat tobacco dependence among PWH. A 3-step Ask-Advise-Connect framework
includes asking about tobacco use routinely during clinical encounters,
advising about tobacco cessation with emphasis on the benefits of cessation,
and actively connecting patients to cessation treatments, including
prescription of pharmacotherapy (preferably varenicline) and direct connection
to behavioral interventions via telephone quitline or other means to increase
the likelihood of a successful quit attempt.
|
|
Email to a Friend